Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer

Figure 5 Comparison of the signature with other prognostic long noncoding RNAs signatures for colorectal cancer. A: The areas under the receiver operating characteristic curve (AUCs) for 1-, 3- and 5-year overall survival for the immune-related long noncoding RNA (lncRNA) signature; B: The AUCs for the N6-methyladenosine-related lncRNA signature; C: The AUCs for the autophagy-related lncRNA signature; D: The AUCs for the fatty acid metabolism-related lncRNA signature; E: The AUCs for the epithelial-mesenchymal transition-related lncRNA signature; F: The AUCs for the tumor mutational burden-related lncRNA signature. 95%CI: 95% confidence interval; AUC: Areas under the receiver operating characteristic curve.